Non Shockable Out of Hospital Cardiac Arrest Clinical Trial
Official title:
CYclosporine A in Non-shockable Out-of-hospital Cardiac Arrest ResUScitation
The investigators hypothesised that cyclosporine A administration at the onset of cardiopulmonary resuscitation, by inhibiting the mitochondrial permeability transition pore, could prevent the post cardiac arrest syndrome and improve outcomes.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment